Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark T Orr

Showing results (1-10 of 50) with videos related to

Pageof 5
Sort By:
Current Topics in Microbiology and Immunology|August 4, 2010
Inhibitory Ly49 receptors on mouse natural killer cellsMark T Orr, Lewis L Lanier
Cell|September 21, 2010
Natural killer cell education and toleranceMark T Orr, Lewis L Lanier
Methods in Molecular Biology (Clifton, N.J.)|October 9, 2016
Assessment of Antigen-Specific Cellular Immunogenicity Using Intracellular Cytokine Staining, ELISpot, and Culture SupernatantsElyse A Beebe, Mark T Orr
Advances in Experimental Medicine and Biology|August 16, 2011
Natural killer cell licensing during viral infectionMark T Orr, Lewis L Lanier
Nature Immunology|March 2, 2010
'Unlicensed' natural killer cells dominate the response to cytomegalovirus infectionMark T Orr, William J Murphy, Lewis L Lanier
Nature Medicine|December 7, 2013
Key roles of adjuvants in modern vaccinesSteven G Reed, Mark T Orr, Christopher B Fox
Proceedings of the National Academy of Sciences of the United States of America|August 25, 2010
Natural killer cells in NOD.NK1.1 mice acquire cytolytic function during viral infection and provide protection against cytomegalovirusMark T Orr, Joshua N Beilke, Irina Proekt, et al.
Current Opinion in Immunology|July 9, 2016
The science of vaccine adjuvants: advances in TLR4 ligand adjuvantsSteven G Reed, Fan-Chi Hsu, Darrick Carter, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 21, 2003
T cell receptor revision does not solely target recent thymic emigrantsCristine J Cooper, Mark T Orr, Catherine J McMahan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 4, 2007
Cutting edge: recombinant Listeria monocytogenes expressing a single immune-dominant peptide confers protective immunity to herpes simplex virus-1 infectionMark T Orr, Nural N Orgun, Christopher B Wilson, et al.
Pageof 5

Showing results (1-10 of 50) with videos related to

Sort By:
Pageof 5
Current Topics in Microbiology and Immunology|August 4, 2010
Inhibitory Ly49 receptors on mouse natural killer cellsMark T Orr, Lewis L Lanier
Cell|September 21, 2010
Natural killer cell education and toleranceMark T Orr, Lewis L Lanier
Methods in Molecular Biology (Clifton, N.J.)|October 9, 2016
Assessment of Antigen-Specific Cellular Immunogenicity Using Intracellular Cytokine Staining, ELISpot, and Culture SupernatantsElyse A Beebe, Mark T Orr
Advances in Experimental Medicine and Biology|August 16, 2011
Natural killer cell licensing during viral infectionMark T Orr, Lewis L Lanier
Nature Immunology|March 2, 2010
'Unlicensed' natural killer cells dominate the response to cytomegalovirus infectionMark T Orr, William J Murphy, Lewis L Lanier
Nature Medicine|December 7, 2013
Key roles of adjuvants in modern vaccinesSteven G Reed, Mark T Orr, Christopher B Fox
Proceedings of the National Academy of Sciences of the United States of America|August 25, 2010
Natural killer cells in NOD.NK1.1 mice acquire cytolytic function during viral infection and provide protection against cytomegalovirusMark T Orr, Joshua N Beilke, Irina Proekt, et al.
Current Opinion in Immunology|July 9, 2016
The science of vaccine adjuvants: advances in TLR4 ligand adjuvantsSteven G Reed, Fan-Chi Hsu, Darrick Carter, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 21, 2003
T cell receptor revision does not solely target recent thymic emigrantsCristine J Cooper, Mark T Orr, Catherine J McMahan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 4, 2007
Cutting edge: recombinant Listeria monocytogenes expressing a single immune-dominant peptide confers protective immunity to herpes simplex virus-1 infectionMark T Orr, Nural N Orgun, Christopher B Wilson, et al.
Pageof 5